RBF Capital’s AdaptHealth AHCO Stock Holding History

RBF Capital’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-100,000	Closed	-$1.12M	–	551
2024 Q3	$1.12M	Hold	100,000	–	–	0.06%	279
2024 Q2	$1M	Sell	100,000 -11,323	-10%	-$115K	0.06%	276
2024 Q1	$1.28M	Buy	111,323 +27,123	+32%	+$230K	0.07%	260
2023 Q4	$614K	Sell	84,200 -39,891	-32%	-$315K	0.04%	352
2023 Q3	$1.13M	Buy	124,091 +64,730	+109%	+$776K	0.07%	242
2023 Q2	$722K	Buy	59,361 +4,361	+8%	+$48.6K	0.05%	308
2023 Q1	$684K	Hold	55,000	–	–	0.05%	294
2022 Q4	$1.06M	Sell	55,000 -75,000	-58%	-$1.59M	0.08%	236
2022 Q3	$2.44M	Sell	130,000 -90,000	-41%	-$1.85M	0.21%	116
2022 Q2	$3.73M	Sell	220,000 -10,000	-4%	-$162K	0.26%	93
2022 Q1	$3.78M	Buy	230,000 +190,000	+475%	+$3.42M	0.24%	103
2021 Q4	$978K	Hold	40,000	–	–	0.06%	270
2021 Q3	$932K	Sell	40,000 -22,855	-36%	-$553K	0.05%	277
2021 Q2	$1.72M	Buy	+62,855	New	+$1.79M	0.1%	200

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RBF Capital's AHCO Position: Q4 2024 in Review

RBF Capital sold out of AdaptHealth (AHCO) in Q4 2024, closing a stake of 100,000 shares — an estimated $1.12M sold.

RBF Capital first reported a position in AHCO in Q2 2021 and held it in 14 quarters. The position peaked at $3.78M in Q1 2022. 200 funds tracked by Wall St. Rank hold AHCO as of Q4 2024.

RBF Capital reported no remaining AdaptHealth position as of Q4 2024 after selling out during the quarter.
RBF Capital sold 100,000 AdaptHealth shares in Q4 2024, an estimated $1.12M.
RBF Capital first reported a position in AdaptHealth in Q2 2021 and held it in 14 quarters.
RBF Capital's AdaptHealth position peaked at $3.78M in Q1 2022.
200 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2024.

Based on RBF Capital's 13F filing for Q4 2024, filed 14 Feb 2025.